 |
pembrolizumab |
|---|---|
| Trade Name | Keytruda |
| Orphan Indication | Gastric cancer, including gastroesophageal junction adenocarcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-06-16 00:00:00 |
| Sponsor | Merck Research Laboratories;351 North Sumneytown Pike, UG2C-50;North Wales, Pennsylvania, 19454 |
